I have sent a few emails tonight to Ekhomed LLC in the Ukraine to the head and number of leading specialists. Obviously stating the fact i first invested in Stirling due to Immunoxel and its exciting benefits to tuberculosis and hiv... very exciting studies they were doing etc.
my questions were based on
1. Mongolia, why did this seem to stop considering initial trials were quite successful.
2. What happened to the approval in South Africa nearly 2 years ago.
3. Obviously the new agreement to supply immunoxel in tablet form, where does Stirling now stand.
4. And a few questions regarding funding and Stirling
and a few others
hopefully i can get a response, if not i will be inclined to call shortly.
I have sent a few emails tonight to Ekhomed LLC in the Ukraine...
Add to My Watchlist
What is My Watchlist?